Follow us on

wmedtour

Search
Close this search box.

Dr. ALI TEKIN

About Dr. ALI TEKIN

Diagnosis and Treatment of Prostate Diseases , Urinary Incontinence and Bladder Health , Urology

Education

  • 2009Duzce University Faculty of Medicine Department of Urology / Professor
  • 2003SB Haydarpaşa Numune Training and Research Hospital Urology Clinic / Associate Professor
  • 1999Hacettepe University Faculty of Medicine Department of Urology / Urooncology
  • 1997Hacettepe University Faculty of Medicine Urology
  • 1992Hacettepe University Faculty of Medicine

Experience

  • 2019Acıbadem Health Group
  • 2007 – 2019Duzce University Faculty of Medicine Department of Urology
  • 2003 – 2007SB Haydarpaşa Numune Training and Research Hospital Urology Clinic / Associate Professor Dr.
  • 2000 – 2003SB Haydarpaşa Numune Training and Research Hospital Urology Clinic / Urology Specialist
  • 1999 – 2000GATA Ankara / Urology Specialist
  • 1997 – 1999Hacettepe University Faculty of Medicine Department of Urology / Lecturer
  • 1992 – 1997Hacettepe University Faculty of Medicine Department of Urology / Research Assistant
Memberships

  • Pediatric Urology Association
  • Turkish Urology Association
  • Urological Surgery Association
  • Minimally Invasive Urology Association
  • European Association of Urology
  • Urooncology Association
PUBLICATIONS

  • Free prostate-specific antigen is a better tool than total prostate-specific antigen at predicting prostate volume in patients with lower urinary tract symptoms.Urology 80: 1088-92, 2012. Kayikci A, Cam K, Kacagan C, Tekin A, Ankarali H.
  • Post prostatic massage examination for prediction of asymptomatic prostatitis in needle biopsies: a prospective study.J Urol 182:564–569, 2009. Tekin A, Yuksel A, Tekin S, Gumrukcu G, Aslan AR, Sengor F.
  • High power Diode 980nm laser vaporisation of the prostate: preliminary results in the surgical management of benign prostate hyperplasia.J Urol 182:1078–82, 2009. Erol A, Cam K, Tekin A, Memik O, Coban S, Ozer Y.
  • Short term effects of GnRH agonists on plasma fibrinolytic balance in patients with advanced prostate cancer.J Thromb Thrombolysis 27:172–4, 2009. Agirbasli M, Baykan OA, Tekin A, Sengor F, Cincin AA, Demir M, Vaughan DE.
  • Intermediate-term functional and cosmetic results of the Snodgrass procedure in distal and midpenile hypospadias.Pediatr Surg Int, 20: 197-199, 2004. Gurdal M, Tekin A, Kirecci S, Sengor F.
  • Nd:YAG laser ablation plus transurethral resection for large prostates in high-risk patients.Urology, 62: 914-917, 2003. Gurdal M, Tekin A, Yucebas E, Sengor F.
  • Radical cystectomy versus alternative treatments for muscle-confined bladder cancer.Int Urol Nephrol, 33: 357-362, 2001. Tekin A, Aki FT, Ozen H.
  • Daily variability of serum prostate-specific antigen in men over 50 years of age.Int Urol Nephrol, 33:641–644, 2001. Tekin A, Atsu N Ozen H.
  • A study on the etiology of idiopathic calcium urolithiasis in children: hypocitraturia is the most important risk factor.J Urol, 164: 162-165, 2000. Tekin A, Tekgul S, Atsu N, Sahin A, Ozen H, Bakkaloglu M.
  • Bilateral germ cell cancer of the testis: a report of 11 patients with a long-term follow-up.BJU International, 85: 864-868, 2000 Tekin A, Aygun YC, Aki FT, Ozen H.